glp 1 colorado springs Weight Loss Center Study: 40% of Colorado Patients

Semaglutide is a GLP-1 receptor agonist medication that may be considered for certain patients as part of a physician-supervised weight-management plan

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending

NPR article:Ozempic shows promise for alcohol and drug addiction

This discovery could lead to a tool enabling medical providers to identify the most effective weight loss interventions based on a person's genetic makeup.

Learn more about the differences in GLP-1 medications, side effects, and which prescription treatment may be the right one for you.